These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23828139)

  • 1. Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma.
    Wang L; Zhu R; Huang Z; Li H; Zhu H
    Dig Dis Sci; 2013 Aug; 58(8):2223-36. PubMed ID: 23828139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway.
    Wang Y; Tu Q; Yan W; Xiao D; Zeng Z; Ouyang Y; Huang L; Cai J; Zeng X; Chen YJ; Liu A
    Biochem Biophys Res Commun; 2015 Jan; 456(1):373-9. PubMed ID: 25475726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide-induced toll-like receptor 4 signaling in esophageal squamous cell carcinoma promotes tumor proliferation and regulates inflammatory cytokines expression.
    Zu Y; Ping W; Deng T; Zhang N; Fu X; Sun W
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27061118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A896G and C1196T Polymorphisms Within the TLR4 Gene Abate Toll-Like Receptor 4-Mediated Signaling in HepG2 Cells.
    Huang C; Zhang H; Bai R; Wang L; Lv J
    DNA Cell Biol; 2017 Nov; 36(11):1029-1038. PubMed ID: 28945461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma.
    Xu D; Wang X; Yan S; Yin Y; Hou J; Wang X; Sun B
    Tumour Biol; 2014 Oct; 35(10):10267-73. PubMed ID: 25034527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cynatratoside-C from Cynanchum atratum displays anti-inflammatory effect via suppressing TLR4 mediated NF-κB and MAPK signaling pathways in LPS-induced mastitis in mice.
    Hu G; Hong D; Zhang T; Duan H; Wei P; Guo X; Mu X
    Chem Biol Interact; 2018 Jan; 279():187-195. PubMed ID: 29113806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4/JNK pathway.
    Dong YQ; Lu CW; Zhang L; Yang J; Hameed W; Chen W
    Mol Immunol; 2015 Dec; 68(2 Pt C):671-83. PubMed ID: 26589455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells.
    Wang Y; Zhang MX; Meng X; Liu FQ; Yu GS; Zhang C; Sun T; Wang XP; Li L; Wang YY; Ding SF; Yang JM; Zhang Y
    Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1743-52. PubMed ID: 21317307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1.
    Yang H; Young DW; Gusovsky F; Chow JC
    J Biol Chem; 2000 Jul; 275(27):20861-6. PubMed ID: 10877845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide.
    Jing YY; Han ZP; Sun K; Zhang SS; Hou J; Liu Y; Li R; Gao L; Zhao X; Zhao QD; Wu MC; Wei LX
    BMC Med; 2012 Aug; 10():98. PubMed ID: 22938142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells.
    Hsiao CC; Chen PH; Cheng CI; Tsai MS; Chang CY; Lu SC; Hsieh MC; Lin YC; Lee PH; Kao YH
    Cancer Lett; 2015 Nov; 368(1):144-152. PubMed ID: 26276725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4.
    Wei X; Liu H; Li X; Liu X
    Ann Hepatol; 2019; 18(6):869-878. PubMed ID: 31477445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
    Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
    Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total flavonoids of Radix Tetrastigma suppress inflammation-related hepatocellular carcinoma cell metastasis.
    Liu Z; Ding F; Shen X
    Mol Genet Genomics; 2021 May; 296(3):571-579. PubMed ID: 33576897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
    Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
    Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent TLR4 Activation Promotes Hepatocellular Carcinoma Growth through Positive Feedback Regulation by LIN28A/Let-7g miRNA.
    Chen IT; Cheng AC; Liu YT; Yan C; Cheng YC; Chang CF; Tseng PH
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPS promotes epithelial-mesenchymal transition and activation of TLR4/JNK signaling.
    Li H; Li Y; Liu D; Liu J
    Tumour Biol; 2014 Oct; 35(10):10429-35. PubMed ID: 25053598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
    Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A
    BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma.
    Zhou S; Du R; Wang Z; Shen W; Gao R; Jiang S; Fang Y; Shi Y; Chang A; Liu L; Liu C; Li N; Xiang R
    Cancer Med; 2019 May; 8(5):2325-2337. PubMed ID: 30957973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine inhibits lipopolysaccharide-induced expression of inflammatory cytokines by suppressing TLR4-mediated NF-ĸB and MAPK signaling pathways in rumen epithelial cells of Holstein calves.
    Zhao C; Wang Y; Yuan X; Sun G; Shen B; Xu F; Fan G; Jin M; Li X; Liu G
    J Dairy Res; 2019 May; 86(2):171-176. PubMed ID: 31142385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.